Figure 1
Triple-negative breast cancers showing (a) nuclear expression of androgen receptor; (b) tumor cell staining for PD-L1; (c) immune cell staining for PD-L1.
Figure 1 | npj Breast Cancer
Triple-negative breast cancers showing (a) nuclear expression of androgen receptor; (b) tumor cell staining for PD-L1; (c) immune cell staining for PD-L1.
